GAITHERSBURG, Md. — Novavax, a Gaithersburg based company currently in the process of developing a COVID-19 vaccine, said Monday they hope to nearly double their workforce by 2024.
Right now the company employs about 450 workers worldwide and plans on adding a majority of the new positions sometime in 2021.
As part of the expansion, Novavax is acquiring 122,000-square-feet of space at 700 Quince Orchard Road, near their headquarters.
Earlier this year, the company was awarded up to $1.6 billion through Operation Warp Speed to develop, manufacture and deliver 100 million vaccine doses.
To assist with expansion costs, Maryland's Department of Commerce has approved a $2 million conditional loan.
They are also eligible for several other state and local grants, loans, and/or tax credits as it relates to job creation and capitol investments.